[
  {
    "ts": null,
    "headline": "West Pharmaceutical: Remains A Strong Long-Term Prospect",
    "summary": "West Pharmaceutical's strong GLP-1 and biologics segment positions it for growth. Click here to read why WST stock is upgraded to a Buy.",
    "url": "https://finnhub.io/api/news?id=5edcb78dcb29437537e1a5c53bfc5f4b0828c602aebab794062001c5d3c896d8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741655753,
      "headline": "West Pharmaceutical: Remains A Strong Long-Term Prospect",
      "id": 133129659,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1384672091/image_1384672091.jpg?io=getty-c-w1536",
      "related": "WST",
      "source": "SeekingAlpha",
      "summary": "West Pharmaceutical's strong GLP-1 and biologics segment positions it for growth. Click here to read why WST stock is upgraded to a Buy.",
      "url": "https://finnhub.io/api/news?id=5edcb78dcb29437537e1a5c53bfc5f4b0828c602aebab794062001c5d3c896d8"
    }
  }
]